BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19223373)

  • 1. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma.
    Salama ME; Rajan Mariappan M; Inamdar K; Tripp SR; Perkins SL
    Int J Surg Pathol; 2010 Apr; 18(2):121-8. PubMed ID: 19223373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD23 expression in mediastinal large B-cell lymphomas.
    Calaminici M; Piper K; Lee AM; Norton AJ
    Histopathology; 2004 Dec; 45(6):619-24. PubMed ID: 15569053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma.
    Hoeller S; Zihler D; Zlobec I; Obermann EC; Pileri SA; Dirnhofer S; Tzankov A
    Histopathology; 2010 Jan; 56(2):217-28. PubMed ID: 20102401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
    Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
    Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediastinal lymphomas: primary mediastinal (thymic) large B-cell lymphoma versus classical Hodgkin lymphoma, histopathologic dilemma solved?
    Pervez S; Khawaja RD
    Pathol Res Pract; 2010 Jun; 206(6):365-7. PubMed ID: 20185248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.
    Hsi ED; Sup SJ; Alemany C; Tso E; Skacel M; Elson P; Alonso MA; Pohlman B
    Am J Clin Pathol; 2006 May; 125(5):776-82. PubMed ID: 16707382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.
    Rodig SJ; Savage KJ; LaCasce AS; Weng AP; Harris NL; Shipp MA; Hsi ED; Gascoyne RD; Kutok JL
    Am J Surg Pathol; 2007 Jan; 31(1):106-12. PubMed ID: 17197926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
    Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
    Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
    Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
    Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livin, a novel marker in lymphoma type distinction.
    Tanhaei AP; Ziaei A; Mazrouei S; Keyhanian K; Salehi M
    Ann Diagn Pathol; 2014 Jun; 18(3):157-62. PubMed ID: 24767895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mediastinal lymphomas: histopathology].
    Chetaille B
    Rev Pneumol Clin; 2010 Feb; 66(1):28-31. PubMed ID: 20207293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma.
    Bakshi NA; Finn WG; Schnitzer B; Valdez R; Ross CW
    Arch Pathol Lab Med; 2007 May; 131(5):742-7. PubMed ID: 17488159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin disease with subsequent transformation to CD30 positive non-hodgkin lymphoma in six patients.
    Mori N; Watanabe K; Yamashita Y; Nakayama A; Yatabe Y; Narita M; Kobayashi T; Hasegawa Y; Kojima H; Nagasawa T
    Cancer; 1999 Feb; 85(4):970-9. PubMed ID: 10091777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pattern of CD15, CD30 and Bcl-2 expression in diffuse large B-cell lymphoma.
    Eow GI; Kim LH; Peh SC
    Med J Malaysia; 2006 Oct; 61(4):416-21. PubMed ID: 17243518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large B-cell lymphoma with Hodgkin's features.
    García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mediastinal large-cell lymphoma of B-cell (thymic?) type. An anatomo-clinical entity in development].
    Sanchez Fayos J; Roman A; Nevado MI
    An Med Interna; 1996 Jan; 13(1):37-9. PubMed ID: 8679823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.